VIVO - Meridian Bioscience, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20179/30/20169/30/2015
Total Revenue200,771196,082194,830
Cost of Revenue75,93868,29572,948
Gross Profit124,833127,787121,882
Operating Expenses
Research Development15,68013,81512,605
Selling General and Administrative65,14361,11353,217
Non Recurring6,6281,4811,481
Others---
Total Operating Expenses---
Operating Income or Loss37,38251,37856,060
Income from Continuing Operations
Total Other Income/Expenses Net689163-997
Earnings Before Interest and Taxes38,07151,54155,063
Interest Expense1,642897897
Income Before Tax36,42950,64455,063
Income Tax Expense14,87218,41519,523
Minority Interest---
Net Income From Continuing Ops21,55732,22935,540
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income21,55732,22935,540
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares21,55732,22935,540